key: cord-0923868-2j6au5sd authors: Zhou, Haiwei; Wang, Conghui; Rao, Jian; Chen, Lan; Ma, Tingting; Liu, Donglai; Ren, Lili; Xu, Sihong title: The impact of Sample Processing on the Rapid Antigen Detection test for SARS-CoV-2: Virus Inactivation, VTM Selection, and Sample Preservation date: 2021-09-09 journal: Biosaf Health DOI: 10.1016/j.bsheal.2021.09.001 sha: e332981881460fcdc4567ade780fd67c3bf1d969 doc_id: 923868 cord_uid: 2j6au5sd Many factors have been identified as having the ability to affect the sensitivity of rapid antigen detection (RAD) tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed to identify the impact of sample processing on the sensitivity of the RAD tests. We explored the effect of different inactivation methods, viral transport media (VTM) solutions, and sample preservation on the sensitivity of four RAD kits based on two SARS-CoV-2 strains. Compared with non-inactivation, heat inactivation significantly impacted the sensitivity of most RAD kits; however, β-propiolactone inactivation only had a minor effect. Some of the VTM solutions (VTM2, MANTACC) had a significant influence on the sensitivity of the RAD kits, especially for low viral-loads samples. The detection value of RAD kits was slightly decreased, while most of them were still in the detection range with the extension of preservation time and the increase of freeze-thaw cycles. Our results showed that selecting the appropriate inactivation methods and VTM solutions is necessary during reagent development, performance evaluation, and clinical application. The global epidemic of coronavirus disease 2019 (COVID-19) has presented a major threat to public health worldwide. COVID-19 is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1] . According to the World Health Organization (WHO) report, as of 22 July 2021, there have been 191,773,590 confirmed cases of COVID-19, including 4,127,963 deaths [2] . Consequently, there is an urgent need for rapid, simple, and accurate tests to diagnose SARS-CoV-2 infection. At present, real-time reverse transcription-polymerase chain reaction (RT-PCR) assay is the gold standard for COVID-19 diagnosis. However, RT-PCR assay requires special equipment, trained personnel, and logistical planning for sample shipment. In addition, it results in communication, which is not conducive for timely prevention and control of the epidemic [3] [4] [5] . Conversely, rapid antigen detection (RAD) tests are simple and take only a few minutes to acquire results. The most important thing is the RAD tests for SARS-CoV-2 have been shown to have comparable sensitivity and specificity as the RT-PCR assay in high viral loads [6] . Hence, the demand for rapid SARS-CoV-2 antigen detection assay substantially increased. Still, the sensitivity of RAD tests, which is very important for epidemic prevention and control, considerably differs across studies [7] [8] [9] [10] [11] . For example, in a recent survey, the average sensitivity of RAD tests was 56.2% (95% CI 29.5 to 79.8%), with average specificity as 99.5% (95% CI 98.1% to 99.9%) [7] . According to the technical guidance of WHO, the effectiveness of the RAD tests depends on several factors, including the concentration of virus in the specimen, the time from onset of illness, the quality of the samples collected from a person, the way that the specimen is processed, and the precise formulation of the reagents in the test kits. At present, there is no systematic study on the effect of the samples' processing, including sample inactivation, VTM selection, and sample preservation on the RAD detection of SARS-Cov-2. This study aimed to identify the impact of sample processing on the sensitivity of the RAD tests. A previous study showed that the volume of the used sample and the dilution factor in the assay diluent tube expressed marked differences in sensitivity on RAD tests [12] . Therefore, we wanted to investigate whether other sample processing conditions affect the sensitivity of RAD tests. Furthermore, we reported on the impact of different sample preservation conditions on RAD tests. Unbound virus was washed away after one h, and cells were then cultured with fresh medium supplemented with 2% FBS at 37°C for 48-72h. The supernatant was then collected and clarified by spinning at 400×g for 10 minutes. One aliquot was used for titration with 50% tissue culture infectivity dose (TCID 50 ), and the other was used for virus inactivation and the RAD detection without freezing and thawing. The infectious titers of two strains used in the study, performed by the Reed and Muench method on Vero cells, were 6.3×10 5 and 3.2×10 5 TCID 50 /mL, respectively. Beta-propiolactone (BPL, Shanghai Macklin Biochemical Co., Ltd.) was used at a dilution of 1:4000, and SARS-CoV-2 stocks were incubated with BPL for 48h at 4°C, after which samples were transferred to 37 °C for two hours to hydrolyze all residual BPL. Microcentrifuge polypropylene tubes (1.5mL) containing the virus were exposed to direct heat in a heat block at 56°C for 30 minutes. After being heated, all samples were left to cool down to room temperature and centrifuged to collect condensation within the tube. The four included RAD tests were supplied by: Guangzhou Wondfo Biotech Co., For investigating the effect of different virus inactivation methods on the sensitivity of RAD kits, we used the 2-fold serial dilutions of two viral stocks and sample matrixes of RAD kits as diluents that included 20 replicates for each dilution, and were applied to LoD determination for 4 RAD kits. The LoD was reported as the level of virus that gives a 95% or higher detection rate. During the evaluation of LoD, results were independently scored by two authors in the form of a band on an immunochromatography paper. In case of discrepant assessments, a third person was consulted to reach a final decision (Wondfo, ACON, and Kinghawk). For investigating the influence of different VTM solutions, viral stocks with high (50×LoD), medium (10×LoD), and low viral loads (2.5×LoD) were treated with four VTM solutions or sample matrixes of RAD kits based on the determined LoD titer of RAD kits. Then the testing was performed using three RAD kits within 30 minutes. hours, -20℃ for one day, three days and seven days, -20℃ freezing and thawing once, twice and three times) based on the determined LoD titer of RAD kits, after which the testing was performed using three RAD kits. The results of colloidal gold RAD test kits were divided into C1-C9 according to the color development intensity from high to low, where B represented negative and C1-C9 represented positive. From C9-C1, the smaller the number, the more antigens bound to the RAD test kits. The results of immunofluorescence RAD test kits were obtained as the T/C ratio of fluorescence value. We divided them into "<0.039" "0.039~0.1" "0.1~0.5" "0.5~1.2" "1.2~2.0" and "2.0~3.0" according to the intensity from low to high, where "<0.039" representing negative and "0.039~3.0" representing positive values. With the increase of the ratio, more antigens tend to bind to the RAD test kits. To investigate the effect of different virus inactivation methods on the sensitivity of RAD kits, two cultures of SARS-CoV-2 strains with varying dilution ratios were selected and divided into three sample inactivation groups: non-inactivation, β-propiolactone inactivation, and heat inactivation [13] . The effect of different inactivation methods on the limit of detection (LoD) of RAD kits was evaluated. The LoD ratio of other inactivation assays revealed that heat inactivation significantly impacted the sensitivity of most RAD kits compared with non-inactivation (8.0 for Kit A and B, 4.0 for Kit D, 2.0 for Kit C). However, β-propiolactone inactivation had only a minor effect on the two tested RAD kits (Table.1 ). Notes: 1 The results are expressed as TCID 50 /mL; 2 the LoD ratio of BPL-inactivated to un-inactivated is calculated; 3 the LoD ratio of heat-inactivated to un-inactivated is calculated. According to the assay, VTM 2 and VTM3 significantly influence the sensitivity of all RAD kits, especially for low viral loads (2.5×LoD) samples, while VTM 1 and VTM 4 had little impact (Fig.1) . Finally, based on the determined LoD of RAD kits, the influence of different virus preservation temperatures and time on the sensitivity of RAD kits were measured. Three virus solutions with high (50×LoD), medium (10×LoD), and low viral loads (2.5×LoD) were used to detect the sensitivity of RAD kits under different storage conditions. The assay showed that with the extension of preservation time and the increase in freeze-thaw cycles, the detection value of RAD kits slightly decreased. Nevertheless, most of them (such as Wondfo Biotech and BIOEASY) were still in the range of detection even for low viral load (2.5×LoD) samples (Fig.2) . This study explored the effect of different inactivation methods, VTM solutions, and sample preservation on the sensitivity of four RAD kits. According to our results, heat inactivation may not be a suitable inactivation method for SARS-CoV-2 testing, especially for clinical testing and performance evaluation. This finding was consistent with a previous study reporting that heat inactivation harmed the efficiency of Our results showed that, along with the extension of preservation time and the increase of freeze-thaw cycles, the detection value of RAD kits slightly decreased, but most of them were still in the range of detection. A previous study showed that the copy number of the DNA target decreased after ten freeze-thaw cycles, which affected the performance of the droplet digital PCR [17] . Also, there was no access to HIV viral load testing when the whole blood was stored in EDTA tubes or plasma preparation tubes for more than 6 hours at 25°C [18] . An overview of COVID-19 WHO Coronavirus (COVID-19) Dashboard Interpreting Diagnostic Tests for SARS-CoV-2 Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples Cochrane COVID-19 Diagnostic Test Accuracy Group. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection Evaluation of a rapid diagnostic assay for detection of SARS CoV-2 antigen in nasopharyngeal swab Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2 Dominic Nc Tsang. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study Inactivation of 2019 new coronary virus before quantitative real-time PCR testing Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples Effects of Storage Time and Freeze-Thawing on the Stability of Bacterial Genomic DNA Evaluated by Droplet Digital PCR Expanding Access to HIV Viral Load Testing: A Systematic Review of RNA Stability in EDTA Tubes and PPT This work was supported by China's National Science and Technology Major Project (2018ZX10102001) and the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019PT310029 2020PT310004). The authors declare that there are no conflicts of interest.